We are live on ! Find out more
PHAS

PhaseBio Pharmaceuticals, Inc. Common Stock

Delisted

PHAS was delisted on the 2nd of November, 2022.

Name Holding Trade Value Shares
Change
Change in
Stake
NMC
1
NEA Management Company
Maryland
$1.17M
APM
2
Avidity Partners Management
Texas
$768K -$44.5K -43,635 -1%
RSCM
3
Rock Springs Capital Management
Maryland
$479K -$56.9K -55,795 -2%
MCM
4
MAI Capital Management
Ohio
$406K +$611K +598,430 +35%
Vanguard Group
5
Vanguard Group
Pennsylvania
$318K
JJ
6
Johnson & Johnson
New Jersey
$283K
BlackRock
7
BlackRock
New York
$116K -$19K -18,641 -3%
DCM
8
DAFNA Capital Management
California
$57K -$57.9K -56,755 -15%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$56K
PTP
10
Platform Technology Partners
New York
$41K -$11.2K -11,000 -5%
BCM
11
Bridgeway Capital Management
Texas
$35K +$76.5K +75,000 +59%
OIA
12
OneDigital Investment Advisors
Kansas
$30K +$158K +155,000 +960%
Acadian Asset Management
13
Acadian Asset Management
Massachusetts
$29K -$102K -99,812 -37%
Jane Street
14
Jane Street
New York
$19K -$2.05K -2,007 -2%
Morgan Stanley
15
Morgan Stanley
New York
$17K -$11.2K -11,003 -10%
State Street
16
State Street
Massachusetts
$16K
Northern Trust
17
Northern Trust
Illinois
$10K
SCA
18
Snowden Capital Advisors
New York
$10K
NFC
19
Northeast Financial Consultants
Connecticut
$7K
UBV
20
United Bank (Virginia)
Virginia
$7K +$10.7K +10,500 +39%
William Blair & Company
21
William Blair & Company
Illinois
$6K
IIA
22
IPG Investment Advisors
California
$5.05K -$204 -200 -0.7%
RJA
23
Raymond James & Associates
Florida
$3K
Stifel Financial
24
Stifel Financial
Missouri
$2K -$434K -425,544 -97%
TRCT
25
Tower Research Capital (TRC)
New York
$2K -$14.9K -14,600 -58%